Abstract | BACKGROUND: METHODS: We enrolled 105 ICH patients and 105 healthy individuals. Admission serum cyclophilin A concentrations were detected in ICH patients. Hemorrhagic severity was assessed using the National Institutes of Health Stroke Scale (NIHSS) and hematoma volume. Modified Rankin Scale score > 2 was defined as a poor outcome. RESULTS: Serum cyclophilin A concentrations were significantly higher in patients than in controls. There was a close correlation of serum cyclophilin A concentrations with NIHSS scores and hematoma volume. Serum cyclophilin A emerged as an independent predictor for 6-month mortality, overall survival and poor outcome. Moreover, it had a strong discriminatory ability for 6-month mortality and poor outcome. Furthermore, it could significantly improve the prognostic predictive ability of NIHSS scores or hematoma volume alone. CONCLUSIONS:
|
Authors | Bin Chen, Jia Shen, Guan-Rong Zheng, Shen-Zhong Qiu, Huai-Ming Yin, Wei Mao, Hong-Xiang Wang, Jian-Bo Gao |
Journal | Clinica chimica acta; international journal of clinical chemistry
(Clin Chim Acta)
Vol. 486
Pg. 162-167
(Nov 2018)
ISSN: 1873-3492 [Electronic] Netherlands |
PMID | 30077639
(Publication Type: Journal Article, Observational Study)
|
Copyright | Copyright © 2018 Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Acute Disease
- Aged
- Cerebral Hemorrhage
(blood, diagnosis)
- Cyclophilin A
(blood)
- Female
- Humans
- Male
- Middle Aged
- Prospective Studies
- Survival Rate
|